"Designing Growth Strategies is in our DNA"

Pediatric Drugs and Vaccines Market Size, Share and Global Trend By Product (Vaccines, Drugs) By Disease Indication (Infectious Disease, Cancer, Allergy And Respiratory, Nervous System Disorders, Cardiovascular Disease, Diabetes, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography Forecast till 2026

Region : Global | Report ID: FBI101010 | Status : Ongoing

 

KEY MARKET INSIGHTS

Pediatric drugs and vaccines refer to the various medical supplies that are utilized for the treatment, prevention, and management of diseases in infants, children, and adolescents. Some of the subspecialties for pediatric drugs and vaccines include pediatric cardiology, pediatric critical care, pediatric oncology, pediatric pulmonology, and pediatric infectious disease. Timely and accurate administration of pediatric drugs and vaccines help children to remain healthy and disease free for the majority of their infancy or adolescence and develop into healthy adults.


Increasing number of births globally combined with the increasing prevalence of pediatric diseases are some of the factors driving the growth of global pediatric drugs and vaccines market. Increasing research and advances in pediatric drugs and vaccines, improvements in the immunization program and the emergence of pediatric drugs and vaccines in the emerging markets are some of the major factors driving the growth of the global pediatric drugs and vaccines market.

To gain extensive insights into the market, Request for Customization

According to the U.S. based non-profit organization Child Trends, in 2016, there were nearly 78 million children below the age of 18, accounting for 23.0% of the total U.S. population. The increasing pediatric population is expected to account for greater demand for pediatric drugs and vaccines and are expected to positively drive the market growth of the global pediatric drugs and vaccines market.


The factors limiting the growth of the global pediatric drugs and vaccines market are the lack of accessibility of pediatric drugs and vaccines in the emerging markets due to lack of awareness and inadequate healthcare infrastructure.


Key Players Covered


Some of the major companies that are present in the global pediatric drugs and vaccines market are Novartis AG, AstraZeneca, GlaxoSmithKline plc, Sanofi, Merck Sharp & Dohme Corp., Pfizer Inc., Mitsubishi Tanabe Pharma Corporation, Bharat Biotech, Zydus Cadila, Serum Institute of India Pvt. Ltd., Panacea Biotec Limited and others.


SEGMENTATION 


























SEGMENTATION



 DETAILS



By Product



· Vaccines


· Drugs



By Disease Indication



· Infectious Disease


· Cancer


· Allergy And Respiratory


· Nervous System Disorders


· Cardiovascular Disease


· Diabetes


· Others



By Distribution Channel



· Hospital Pharmacies


· Retail Pharmacies


· Online Pharmacies



By Geography



· North America (USA and Canada)


· Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)


· Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)


· Latin America (Brazil, Mexico and Rest of Latin America)


· Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)



 


In 2018, among the distribution channel, vaccines dominated the global pediatric drugs and vaccines market due to the increase in high investment by pharmaceutical industries for the development of the pediatric vaccines and increased awareness about vaccination globally. This segment is projected to grow at comparatively higher CAGR during the forecast period.


Key Insights



  • Prevalence of pediatric diseases - by key countries,

  • Overview of national immunization programs – by key countries

  • New product launches & approvals

  • Recent industry developments such as partnerships, mergers, and acquisitions


Regional Analysis


North America dominated the global pediatric drugs and vaccines market in 2018. A large proportion of children in the region, increasing treatment options for pediatric diseases, established healthcare system and high per capita healthcare spending are some of the factors driving the growth of the pediatric drugs and vaccines market in the region. Easy access to advanced pediatric drugs and vaccines diagnostics due to advancements in research & development, increasing awareness regarding vaccination programs, and rising demand for preventive medical care are some factors anticipated to drive the growth of the pediatric drugs and vaccines market in North America. Asia Pacific is expected to grow at a significant CAGR during the forecast period due to the increasing awareness of pediatric diseases, increasing access to advanced pediatric drugs and vaccines, increasing disposable incomes and developing healthcare systems.


Key Industry Developments



  • In May 2018, Novartis AG, received US Food and Drug Administration (FDA) approval Gilenya (fingolimod) for the treatment of children and adolescents with relapsing forms of multiple sclerosis (RMS), making it the first disease-modifying therapy indicated for these patients.
  • In May 2018, UCB S.A., received U.S. Food and Drug Administration (FDA) approval for a supplemental new drug application (sNDA) for the anti-epileptic drug (AED) BRIVIACT (brivaracetam) CV oral formulations indicated as monotherapy and adjunctive therapy in the treatment of partial-onset (focal) seizures in patients age four years and older.

Pediatric Drugs and Vaccines Market Size, Share and Global Industry Trend Forecast till 2026
  • Ongoing
  • 2019
  • 2016-2018

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization

Healthcare Clients

Intuitive_Surgical_logo
lpsos
SUANFARMA
Ge-Healthcare
novo-nordisk

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X